16 October 2019 - by Christine Ferro, Kate Fitch, Sean Pittinger
This paper analyzes the healthcare costs incurred by Medicare beneficiaries with newly diagnosed blood cancer including acute leukemia, chronic leukemia, lymphoma, multiple myeloma, and bone marrow disorders.
07 February 2018 - by Christine Ferro, Pamela M. Pelizzari, Sean Pittinger, Bruce S. Pyenson
This report compares the 36-month cancer survival rate by treatment facility type for 46,762 Medicare fee-for-service patients treated with chemotherapy under the Medicare Part B benefit for breast, colon, lung, ovarian, pancreatic, or prostate cancer.